) The Pittsburgh Cancer Institute (PCI) is a multidisciplinary cancer research center, with programs in basic research, translational research and clinical investigations, prevention and control, early diagnosis and treatment, and behavioral medicine research. In addition, it has responsibility for cancer education and clinical care. The PCI is comprised of faculty from the University of Pittsburgh and utilizes the clinical facilities of the University of Pittsburgh Medical Center plus two University affiliated hospitals (Children's Hospital of Pittsburgh and Magee Womens Hospital). In addition, Carnegie Mellon University and its faculty are affiliated with the PCI. The PCI has established programs in: cancer metastasis and cell biology, molecular carcinogenesis, immunology, molecular oncology, experimental therapeutics, clinical investigations, hematopoiesis and hematologic malignancies, biological therapeutics, cancer control and prevention, and behavioral medicine and oncology. To assist its research efforts, the PCI maintains shared facilities including: Biostatistics Facility, Clinical Research Support Services, Immunologic Monitoring Facility, Tissue Procurement Facility, Hybridoma Facility, Flow Cytometry Facility, Protein Sequencing Facility, Peptide Synthesis Facility, Animal Facility, Glassware Facility, Oligonucleotide Synthesis Facility, Cytogenetics Facility, Pharmacy Facility, Clinical Pharmacology Facility, and Cell and Tissue Imaging Facility. This application requests continued Cancer Center support grant (CCSG) funding for the Pittsburgh Cancer Institute's programs for years 08-12.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Cancer Centers and Research Programs Review Committee (CCRP)
Program Officer
Vembu, Devi
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
Schools of Medicine
United States
Zip Code
Posluszny, Donna M; Bovbjerg, Dana H; Agha, Mounzer E et al. (2018) Patient and family caregiver dyadic adherence to the allogeneic hematopoietic cell transplantation medical regimen. Psychooncology 27:354-358
Li, Chunlei; Song, Baobao; Santos, Patricia M et al. (2018) Hepatocellular cancer-derived alpha fetoprotein uptake reduces CD1 molecules on monocyte-derived dendritic cells. Cell Immunol :
Thakur, Prakash C; Miller-Ocuin, Jennifer L; Nguyen, Khanh et al. (2018) Inhibition of endoplasmic-reticulum-stress-mediated autophagy enhances the effectiveness of chemotherapeutics on pancreatic cancer. J Transl Med 16:190
Roy, Somak; LaFramboise, William A; Liu, Ta-Chiang et al. (2018) Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times. Gastroenterology 154:2060-2063.e8
Thapa, Dharendra; Wu, Kaiyuan; Stoner, Michael W et al. (2018) The protein acetylase GCN5L1 modulates hepatic fatty acid oxidation activity via acetylation of the mitochondrial ?-oxidation enzyme HADHA. J Biol Chem 293:17676-17684
Willis, John; Epperly, Michael W; Fisher, Renee et al. (2018) Amelioration of Head and Neck Radiation-Induced Mucositis and Distant Marrow Suppression in Fanca-/- and Fancg-/- Mice by Intraoral Administration of GS-Nitroxide (JP4-039). Radiat Res 189:560-578
Samal, Jasmine; Kelly, Samantha; Na-Shatal, Ali et al. (2018) Human immunodeficiency virus infection induces lymphoid fibrosis in the BM-liver-thymus-spleen humanized mouse model. JCI Insight 3:
Hartman, Douglas J; Ahmad, Fahad; Ferris, Robert L et al. (2018) Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma. Oral Oncol 86:278-287
Jin, Tao; Iordanova, Bistra; Hitchens, T Kevin et al. (2018) Chemical exchange-sensitive spin-lock (CESL) MRI of glucose and analogs in brain tumors. Magn Reson Med 80:488-495
Chen, George L; Carpenter, Paul A; Broady, Raewyn et al. (2018) Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease. Biol Blood Marrow Transplant 24:373-380

Showing the most recent 10 out of 1187 publications